(© Medical Pharma Resource GmbH &  Images ©: https://de.123rf.com/profile_istanbul2009; https://de.123rf.com/profile_solerf)

Langenfeld, 2202-04-11
  • Successful market entry of Medical Pharma Resource (Medical Pharma) and Beacon Medical Germany with Beacon I-Hybrid THC 18 – Wappa in Germany.
  • Medical Pharma and Beacon Medical Germany deepen their exclusive partnership and provide German patients with additional therapeutic options based on the new strain Beacon Indica THC 18 – Sensi Star
  • Medical Pharma expands their product portfolio with the cannabis strain Bedrocan® 22/1, Dronabinol- and the Cannabidiol-Kits

The German market entry of the first exclusive product from Beacon Medical Germany is going very well for both partners. The Beacon I-Hybrid THC 18 – Wappa was previously not available in Germany and is very well requested by treating physicians and patients as a result of the excellent quality.

Medical Pharma and Beacon Medical Germany set on high-quality and full transparency for the imported cannabis products from Canada. Offering up-to-date terpene analyses for the imported batches will help the treating physicians and, above all, the patients to receive an efficient therapy.

The next important milestone for both partners is the timely launch of Beacon Indica THC 18 – Sensi Star from Canada. This new cultivar from Beacon Medical Germany was also not available in Germany before and will provide treating physicians and patients with new therapy options.

Engin Ates, CEO and Co-Founder of Medical Pharma, says: “Our long experience and close collaboration with VIVO’s German subsidiary, Beacon Medical Germany GmbH, will ensure for patients in Germany a new quality standard in medical cannabis therapy. With Harvest Medicine, VIVO’s patient-centered network of medical cannabis clinics that has served over 150,000 patient visits, we will continue to provide treating physicians and patients in Germany with new therapeutic options in the form of medicinal cannabis flowers.”

Medical Pharma will expand by Fall the product portfolio with the strain Bedrocan® 22/1, Dronabinol- and Cannabidiol-Kits to support the therapies and treatments in Germany.

The successful launch of the partnership between Medical Pharma Resource GmbH and Beacon Medical Germany GmbH is the foundations for a long collaboration. New cannabis products from Beacon’s large Canadian product portfolio will follow. Which products exactly will stay a secret of both companies for the time being.

 

About Medical Pharma Resource ®

Medical Pharma Resource (MPR) GmbH was founded at the end of 2018 and is based in Langenfeld. Our pharmaceutical wholesale is focussed on the import, storage, manufacturing, distribution and export of prescription medical cannabis products and therapeutic devices.

We are licensed pharmaceutical wholesalers according to § 52a of the German Medicines Act (AMG) and have a permit to handle narcotics according to § 3 of the Federal Institute for Drugs and Medical Devices (BtMG).

The official inspection for obtaining the manufacturing license in accordance with § 13 AMG and the import license according to § 72 AMG was already carried out by the responsible District Government in February 2022.

 

The philosophy of Medical Pharma

Our company philosophy is simple. Our goal is to provide German patients with high-quality, transparent and traceable medical cannabis products in a timely and sustainable manner.

We are committed to consider important quality criteria in the selection of manufacturers and products, in order to provide the treating physicians and especially the patients with enhanced therapy options.

The Medical Pharma distribution platform offers the own products, the partner products from all over the world and also specific products from German competitors.

 

About VIVO Cannabis ™

VIVO Cannabis is recognized for trusted, premium cannabis products and services in Canada It holds cultivation, processing and sales licenses from Health Canada and operates world-class state of the art indoor and seasonal cultivation facilities. VIVO has a collection of premium brands in Canada, each targeting different customer segments, including Canna Farms ™, Beacon Medical ™, Fireside ™, Fireside-X ™ and Lumina ™. Harvest Medicine ™, VIVO’s client-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.
For more information, visit: VIVO Cannabis Inc. and Beacon Medical Germany

Business partner

We invite you to join us as a partner with your resources and participate proactively in the supply chain of the German & EU medical cannabis market. A good medical alternative with fewer risks and side effects.
As a partner we can guarantee you security, continuity, transparency and trust.
Contact:
business(@)mp-resource(.)com
Internal forwarding: Click on “CONTINUE” please

PR-Contact

Dr. Daniel König
+49 (0) 2173 940 95 91
presse(@)mp-resource(.)com